Basit öğe kaydını göster

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

dc.contributor.authorBilir, Cemil
dc.contributor.authorYıldız, Ibrahim
dc.contributor.authorBilici, Ahmet
dc.contributor.authorUçar, Mahmut
dc.contributor.authorBerk, Veli
dc.contributor.authorYıldız, Yaşar
dc.contributor.authorCinemre, Hakan
dc.contributor.authorTanrıverdi, Özgür
dc.date.accessioned2020-11-20T14:54:56Z
dc.date.available2020-11-20T14:54:56Z
dc.date.issued2017
dc.identifier.issn0735-7907
dc.identifier.issn1532-4192
dc.identifier.urihttps://doi.org/10.1080/07357907.2017.1292518
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2190
dc.descriptionWOS: 000399505100004en_US
dc.descriptionPubMed ID: 28333566en_US
dc.description.abstractBackground: There are insufficient predictive markers for renal cell carcinoma (RCC). Methods: A total of 308 metastatic RCC patients were analyzed retrospectively. Results: The increased hemoglobin (Hb) group had significantly higher progression-free survival and overall survival (OS) compared with the decreased Hb group at 11.5 versus 6.35months (p < .001) and 21.0 versus 11.36months (p < .001) respectively. The 1- and 3-year OS rates were higher in the Hb increased group, i.e., 84% versus 64% and 52% versus 35% respectively. Conclusions: The present study showed that increased Hb levels after tyrosine kinase inhibitor therapy could be a predictive marker of RCC.en_US
dc.item-language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHemoglobinen_US
dc.subjectPredictiveen_US
dc.subjectRenal Cell Carcinomaen_US
dc.subjectSurvivalen_US
dc.subjectTyrosine Kinase Inhibitoren_US
dc.titleIs Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Studyen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorTanrıverdi, Özgür
dc.identifier.doi10.1080/07357907.2017.1292518
dc.identifier.volume35en_US
dc.identifier.issue4en_US
dc.identifier.startpage248en_US
dc.identifier.endpage255en_US
dc.relation.journalCancer Investigationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail
Ad:
Bilir.pdf
Boyut:
1.165Mb
Biçim:
PDF
Açıklama:
Tam metin / Full text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster